Dexketoprofen Trometamol

Producer:Huangshi Shixing Pharmaceutical Co., Ltd., established on June 16, 2004, is a private enterprise and other limited liability companies.

The company has focused on the R & D and production of chemical APIs for nearly 30 years, has production and inspection plants, equipment, instruments and supporting facilities in line with China's GMP standards, and has a perfect platform for API R & D and pilot test. Through independent research and development and industry university research cooperation, it has obtained a number of product core technologies, and the quality of its main products has reached the standards of the United States Pharmacopoeia (USP) and the European Pharmacopoeia (EP).

The company is a national "high-tech enterprise", "AAA credit enterprise", a "science and technology small giant enterprise" in the subdivided field of pillar industries in Hubei Province, and a specialized and new "small giant" enterprise in Hubei Province. The company's technology center was recognized as the "provincial enterprise technology center" in 2019, with an average annual R & D cost of more than 10 million yuan. Now it has many invention patents and more than 130 R & D personnel. It has passed the three management system certification of ISO9001 quality, ISO14001 environment and iso45001 occupational health and safety, has the right of self import and export, and has obtained the registration certificate of customs declaration unit issued by China Customs.

Staff size:300-399 persons

Registered capital:RMB 250 million